Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0OX0V
|
||||
Former ID |
DNC005883
|
||||
Drug Name |
2-(4-ethylthiobenzimidazol-2-yl)quinoxaline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527933] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H14N4S
|
||||
Canonical SMILES |
CCSC1=CC=CC2=C1N=C(N2)C3=NC4=CC=CC=C4N=C3
|
||||
InChI |
1S/C17H14N4S/c1-2-22-15-9-5-8-13-16(15)21-17(20-13)14-10-18-11-6-3-4-7-12(11)19-14/h3-10H,2H2,1H3,(H,20,21)
|
||||
InChIKey |
IHVQPVYBIZVMSJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [527933] | |
Adenosine A1 receptor | Target Info | Inhibitor | [527933] | ||
Adenosine A3 receptor | Target Info | Inhibitor | [527933] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.